HIV Entry Inhibitors and Treatments
45 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the primary function of Entry Inhibitors in the context of HIV treatment?

  • To block the fusion of the HIV with the host cell (correct)
  • To enhance CD4 receptor activity
  • To inhibit reverse transcription processes
  • To prevent the replication of viral RNA
  • Which drug is classified as a CCR5 coreceptor antagonist?

  • Ibalizumab
  • Fostemsavir
  • Enfuviritide
  • Maraviroc (correct)
  • Which of the following best describes the mechanism of Ibalizumab?

  • It acts as a fusion inhibitor during viral entry.
  • It is a CD4 post-attachment inhibitor. (correct)
  • It blocks the gp120 attachment to the CD4 receptor.
  • It inhibits reverse transcription of viral RNA.
  • What is the role of gp120 in the HIV entry process?

    <p>To attach to the host's CD4 receptor.</p> Signup and view all the answers

    Which class of antiretroviral therapy includes NRTIs?

    <p>Reverse Transcriptase Inhibitors</p> Signup and view all the answers

    What is the distinguishing feature of Fusion Inhibitors?

    <p>They block the fusion of viral and host cell membranes.</p> Signup and view all the answers

    Which entry inhibitor binds directly to the HIV virus?

    <p>Enfuviritide</p> Signup and view all the answers

    In terms of therapeutic classification, which drug is a CD4 receptor blocker?

    <p>Ibalizumab</p> Signup and view all the answers

    What is the mechanism of action of Fostemsavir?

    <p>Binding to the HIV gp120 subunit</p> Signup and view all the answers

    What type of drug is Fostemsavir classified as?

    <p>CD4/gp120 Attachment Inhibitor</p> Signup and view all the answers

    What is a critical monitoring parameter for patients on Fostemsavir?

    <p>ALT and AST levels</p> Signup and view all the answers

    Why should Fostemsavir not be used with CYP3A4 inducers?

    <p>They decrease the effectiveness of Fostemsavir</p> Signup and view all the answers

    In which stage of the HIV life cycle does Fostemsavir act?

    <p>Binding/Attachment</p> Signup and view all the answers

    Which of the following describes Fostemsavir's formulation?

    <p>Tablet</p> Signup and view all the answers

    What conversion occurs before Fostemsavir becomes active?

    <p>Conversion to temsavir</p> Signup and view all the answers

    What is the primary mechanism of action of nucleoside reverse transcriptase inhibitors (NRTIs)?

    <p>They mimic human nucleotides and lead to chain termination.</p> Signup and view all the answers

    Which characteristic distinguishes NRTIs from natural nucleotides?

    <p>NRTIs have a modified structure that prevents further nucleotide addition.</p> Signup and view all the answers

    Which of the following drugs is classified as a nucleoside reverse transcriptase inhibitor?

    <p>Tenofovir disoproxil fumarate</p> Signup and view all the answers

    What is a common outcome when NRTIs are incorporated into HIV DNA?

    <p>Termination of the viral DNA chain occurs.</p> Signup and view all the answers

    How do NRTIs affect the translation of HIV RNA?

    <p>They prevent HIV RNA from being converted to DNA.</p> Signup and view all the answers

    Which of the following options best describes the role of triphosphorylated NRTIs?

    <p>They compete with human nucleotides for incorporation into viral DNA.</p> Signup and view all the answers

    What is a primary difference between TDF and TAF concerning side effects?

    <p>TAF has lower bone and renal side effects than TDF.</p> Signup and view all the answers

    Which combination includes Tenofovir disoproxil fumarate?

    <p>Emtricitabine / Tenofovir disoproxil fumarate (Truvada)</p> Signup and view all the answers

    Which of the following is true about how TDF and TAF are activated within the body?

    <p>Both TDF and TAF are hydrolyzed and phosphorylated intracellularly.</p> Signup and view all the answers

    What unique administration route is noted for zidovudine?

    <p>Administered intravenously to mothers with HIV at the time of delivery.</p> Signup and view all the answers

    What are the recommended monitoring parameters for patients on nucleoside reverse transcriptase inhibitors?

    <p>Liver function tests and renal function.</p> Signup and view all the answers

    Which of the following side effects is associated with nucleoside reverse transcriptase inhibitors?

    <p>Lactic acidosis.</p> Signup and view all the answers

    What distinguishes TAF from TDF in terms of prodrug conversion?

    <p>TAF is hydrolyzed and then phosphorylated inside HIV cells.</p> Signup and view all the answers

    Which nucleoside reverse transcriptase inhibitor combination is used for pre-exposure prophylaxis (PrEP)?

    <p>Emtricitabine / Tenofovir disoproxil fumarate (Truvada)</p> Signup and view all the answers

    What role does the HIV integrase enzyme play in the HIV life cycle?

    <p>It integrates HIV DNA into the host's DNA.</p> Signup and view all the answers

    What is the primary function of Integrase Strand Transfer Inhibitors (INSTIs)?

    <p>To block the HIV integrase enzyme from functioning.</p> Signup and view all the answers

    What happens to HIV DNA when the integrase enzyme is inhibited by an INSTI?

    <p>HIV DNA is degraded by the host's repair enzymes.</p> Signup and view all the answers

    Which of the following statements accurately describes the function of the HIV integrase enzyme?

    <p>It binds to the ends of HIV DNA and facilitates integration.</p> Signup and view all the answers

    What occurs during the integrase strand transfer step in the HIV life cycle?

    <p>HIV DNA is integrated into the host's chromosomes.</p> Signup and view all the answers

    How do INSTIs affect the overall replication process of HIV?

    <p>They inhibit the integration of viral DNA into host DNA.</p> Signup and view all the answers

    Why is preventing the integration of HIV DNA into host DNA significant in antiretroviral therapy?

    <p>It stops HIV from making copies of itself.</p> Signup and view all the answers

    What is the result of successful binding of INSTIs to the HIV integrase enzyme?

    <p>HIV cannot integrate its DNA into the host genome.</p> Signup and view all the answers

    What is the primary function of protease inhibitors in the treatment of HIV?

    <p>To inhibit the protease enzyme responsible for viral maturation</p> Signup and view all the answers

    Which mechanism does Lenacapavir utilize to act as an HIV capsid inhibitor?

    <p>It binds to the HIV gp-24 subunit of the viral capsid</p> Signup and view all the answers

    What type of resistance does the protease inhibitor profile demonstrate?

    <p>Favorable resistance allowing for use as second-line options</p> Signup and view all the answers

    What components are encased by the HIV capsid?

    <p>HIV RNA and reverse transcriptase</p> Signup and view all the answers

    Why are protease inhibitors considered for patients who have failed other anti-retroviral therapies?

    <p>They have an overall favorable resistance profile</p> Signup and view all the answers

    Which mutation types are associated with protease inhibitor resistance?

    <p>Primary mutations and mutations distant from the active site</p> Signup and view all the answers

    What is a consequence of the HIV capsid being disrupted by an inhibitor like Lenacapavir?

    <p>Prevention of the capsid's transport through the nuclear pore complex</p> Signup and view all the answers

    What is a characteristic of the protease enzyme in HIV?

    <p>It is crucial for the assembly of new viruses</p> Signup and view all the answers

    Study Notes

    Presentation Title

    • The presentation is titled "Human Immunodeficiency Virus Pharmacology of Anti-Retroviral Therapy"
    • The presenter is Akshith Dass, PharmD, BCIDP, BCPS, Assistant Professor of Pharmacy Practice at NEOMED.
    • The date of the presentation is December 6th, 2024
    • Slide credits are attributed to Bhavin Mistry, PharmD, BCIDP, BCPS

    Learning Objectives

    • Describe the life cycle of HIV
    • Describe the mechanism of action of anti-retroviral agents
    • Distinguish the brand and generic names of anti-retroviral agents
    • Appraise unique positive and negative attributes of anti-retroviral agents

    HIV Anti-Retroviral Therapy Resources

    • The presentation includes references to various resources for HIV Anti-Retroviral Therapy, including National HIV Curriculum question banks and relevant textbooks, such as Pharmacotherapy Principles & Practice (6th ed.) and Goodman & Gilman's: The Pharmacological Basis of Therapeutics (14th ed.).
    • Specific URLs or website addresses to resources are included

    HIV Life Cycle

    • The HIV life cycle is described step-by-step in the presentation
    • HIV enters a host cell
    • The viral RNA is converted to DNA, which then integrates into the host cell's DNA
    • New viral RNA and proteins are produced
    • The new viral particles bud off from the host cell
    • "protease" breaks down proteins
    • A diagram illustrating the HIV life cycle is included.

    HIV Life Cycle with Anti-Retroviral Therapy

    • A diagram illustrates the HIV life cycle and the points at which antiretroviral drugs act.
    • Specific drug classes are shown with reference to their points of intervention.

    Drug Classes

    • Entry inhibitors, Nucleoside/tide Reverse Transcription Inhibitors (NRTIs), Non-Nucleoside Reverse Transcription Inhibitors (NNRTIs), Integrase Inhibitors (INSTIs), Protease Inhibitors (PIs), and Capsid inhibitors are named as drug classes in the presentation.

    HIV Entry Inhibitors

    • Inhibitors are listed to block the HIV entry process
    • Fostemsavir, Ibalizumab, Maraviroc, and Enfuvirtide block different stages of HIV entry.

    CD4/gp120 Attachment Inhibitor

    • Fostemsavir (Rukobia) is a drug to block HIV attachment
    • Mechanism of action: Prodrug converted to temsavir, acting on gp120 to stop interaction with the host CD4 receptor.

    CD4-Post Attachment Inhibitor

    • Ibalizumab(Trogarzo) intervenes after gp120 binds, preventing structural changes needed for viral entry.

    CCR5 Receptor Antagonist: Maraviroc

    • Maraviroc (Selzentry) prevents HIV binding by blocking the CCR5 chemokine receptor.
    • Maraviroc only works with CCR5 coreceptor.

    Fusion Inhibitor: Enfuvirtide

    • Enfuvirtide (Fuzeon) is a fusion inhibitor interfering with HIV gp41 function.

    Reverse Transcriptase Inhibitors

    • The presentation describes the mechanism of nucleoside and non-nucleoside reverse transcriptase inhibitors (NRTIs and NNRTIs), highlighting that they both prevent HIV RNA from being turned into HIV DNA.

    Nucleoside Reverse Transcriptase Inhibitors (NRTIs)

    • The presentation describes that NRTIs are tri-phosphorylated and mimic human nucleotides, but unlike human nucleotides, they don't have a 3'-hydroxyl group. This prevents reverse transcriptase from adding additional nucleotides to the growing chain, stopping the conversion of HIV RNA to DNA.
    • The presentation lists specific drugs, as well as combination drugs, under the category of NRTIs.

    Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

    • NNRTIs bind to a pocket near the active site on the reverse transcriptase enzyme preventing HIV RNA to be converted to HIV DNA. They cause a conformational change.
    • A series of NNRTI drug names are listed.

    INSTI (Integrase Strand Transfer Inhibitors)

    • INSTIs block the HIV integrase gene process, preventing HIV DNA from integrating into the host DNA, which is needed to reproduce copies of the virus.
    • Various drugs under the INSTI category are named.

    HIV Protease Inhibitors (PIs)

    • PIs bind to the HIV protease enzyme active site, halting the maturation process of HIV, preventing the infection of healthy cells.
    • Atazanavir(Reyataz) and Darunavir (Prezista) are protease inhibitors under discussion.

    Boosters or Pharmacokinetic Enhancers

    • Ritonavir (Norvir) and Cobicistat (Tybost) are named as boosters for other PIs, enhancing the concentration of other active compounds.

    Protease Inhibitor Combinations

    • Various protease inhibitor combinations are detailed.

    Generalizing the Pl's/NRTIs/NNRTIs/INSTIs

    • Presentation covers important general aspects of the drugs. Information includes metabolization by the body and important side effects.

    Agent-Specific Toxicity

    • Various drugs and their associated toxicities are noted.

    INSTI - Resistance

    • INSTI resistance is rare.
    • In some cases, INSTIs can be used even if HIV resistance to other drugs is present.

    HIV Capsid Inhibitor

    • This section describes lenacapavir (Sunlenca), a capsid inhibitor that blocks viral capsid structure and function, hindering viral maturation.

    HIV Capsid Inhibitor - Lenacapavir Factoids

    • The presentation includes information about lenacapavir's administration: two induction regimens, injection sites, and monitoring parameters, like serum creatinine.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    HIV Pharmacology PDF

    Description

    Test your knowledge on the different classes of antiretroviral drugs, specifically focusing on entry inhibitors in HIV treatment. The quiz covers critical aspects such as mechanisms of action, drug classifications, and monitoring parameters related to these therapies.

    More Like This

    HIV Treatment in Pregnant Women
    5 questions
    HIV Initial Treatment Regimens
    44 questions
    HIV Awareness and Treatment Quiz
    45 questions
    Use Quizgecko on...
    Browser
    Browser